Alex Luedtke

ORCID: 0000-0002-9936-3236
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Statistical Methods and Inference
  • Advanced Causal Inference Techniques
  • Statistical Methods in Clinical Trials
  • Mental Health Research Topics
  • Mental Health Treatment and Access
  • Suicide and Self-Harm Studies
  • SARS-CoV-2 and COVID-19 Research
  • Health Systems, Economic Evaluations, Quality of Life
  • COVID-19 Clinical Research Studies
  • Digital Mental Health Interventions
  • Vaccine Coverage and Hesitancy
  • Treatment of Major Depression
  • Machine Learning and Data Classification
  • Statistical Methods and Bayesian Inference
  • HIV Research and Treatment
  • Bayesian Modeling and Causal Inference
  • Posttraumatic Stress Disorder Research
  • Machine Learning and Algorithms
  • Bayesian Methods and Mixture Models
  • Child and Adolescent Psychosocial and Emotional Development
  • Adversarial Robustness in Machine Learning
  • HIV/AIDS Research and Interventions
  • Resilience and Mental Health
  • vaccines and immunoinformatics approaches
  • Multi-Criteria Decision Making

University of Washington
2018-2025

Fred Hutch Cancer Center
2018-2025

Park University
2021-2023

Université Paris Cité
2021-2023

Walter de Gruyter (Germany)
2021-2023

College Station Medical Center
2021-2023

Seattle University
2018-2022

Cancer Research Center
2022

Leiden University Medical Center
2020

University of California, Berkeley
2019

Abstract Background Heterogeneity of treatment effects (HTEs) can occur because either differential compliance or effectiveness. This distinction is important, as it has action implications, but unclear how to distinguish these two possibilities statistically in precision analysis given that not observed until after randomization. We review available statistical methods and illustrate a recommended method secondary trial focused on HTE. Methods The randomized n = 880 anxious and/or depressed...

10.1002/mpr.70005 article EN cc-by-nc-nd International Journal of Methods in Psychiatric Research 2025-01-08

Clinical trials have documented numerous clinical features, social characteristics, and biomarkers that are “prescriptive” predictors of depression treatment response, is, which types treatments best for patients. On the basis these results, research is actively under way to develop multivariate prescriptive prediction models guide precision planning. However, sample size requirements such not been analyzed. We present an analysis here. Simulations using realistic parameter values a...

10.1177/2167702618815466 article EN Clinical Psychological Science 2019-01-18

Several vaccine candidates to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or disease 2019 (COVID-19) have entered will soon enter large-scale, phase 3, placebo-controlled randomized clinical trials. To facilitate harmonized evaluation and comparison of the efficacy these vaccines, a general set endpoints is proposed, along with considerations guide selection primary on basis statistical reasoning. The plausibility that protection symptomatic...

10.7326/m20-6169 article EN Annals of Internal Medicine 2020-10-22

The months after psychiatric hospital discharge are a time of high risk for suicide. Intensive postdischarge case management, although potentially effective in suicide prevention, is likely to be cost-effective only if targeted at high-risk patients. A previously developed machine learning (ML) model showed that suicides can predicted from electronic health records and geospatial data, but it unknown prediction could improved by adding additional information. To determine whether information...

10.1001/jamapsychiatry.2022.4634 article EN JAMA Psychiatry 2023-01-18

HIV type 1 (HIV-1) remains a global health concern, with the greatest burden in sub-Saharan Africa. Despite 40 years of research, no vaccine candidate has shown durable and protective efficacy against HIV-1 acquisition. Although pre-exposure prophylaxis groups high vulnerability can be very effective, barriers to its use, such as perceived low acquisition risk, fear stigma, concerns about side-effects, remain. Thus, population-based approach, an vaccine, is needed. The current study aimed...

10.1016/s1473-3099(24)00358-x article EN cc-by The Lancet Infectious Diseases 2024-07-20

We consider the problem of selecting optimal subgroup to treat when data on covariates are available from a randomized trial or observational study. distinguish between four different settings including: (1) treatment selection resources constrained; (2) not (3) in presence side effects and costs; (4) maximize effect heterogeneity. show that, each these cases, rule involves treating those for whom predicted mean difference outcomes comparing with versus without treatment, conditional...

10.1097/ede.0000000000000991 article EN cc-by-nc-nd Epidemiology 2019-02-21

Clinical trials have identified numerous prescriptive predictors of mental disorder treatment response, ie, which treatments are best for patients. However, none these is strong enough alone to guide precision planning. This has prompted growing interest in developing rules (PTRs) that combine information across multiple predictors, but this work been much less successful psychiatry than some other areas medicine. Study designs and analysis schemes used research on PTR development medicine...

10.1001/jamapsychiatry.2021.2500 article EN JAMA Psychiatry 2021-09-24

Time is of the essence in evaluating potential drugs and biologics for treatment prevention COVID-19. There are currently 876 randomized clinical trials (phase 2 3) treatments COVID-19 registered on clinicaltrials.gov. Covariate adjustment a statistical analysis method with to improve precision reduce required sample size substantial number these trials. Though covariate recommended by U.S. Food Drug Administration European Medicines Agency, it underutilized, especially types outcomes...

10.1111/biom.13377 article EN public-domain Biometrics 2020-09-26

10.1080/01621459.2025.2476780 article EN Journal of the American Statistical Association 2025-03-13

We propose a unified framework for automatic debiased machine learning (autoDML) to perform inference on smooth functionals of infinite-dimensional M-estimands, defined as population risk minimizers over Hilbert spaces. By automating estimation and procedures in causal semiparametric statistics, our enables practitioners construct valid estimators complex parameters without requiring specialized expertise. The supports Neyman-orthogonal loss functions with unknown nuisance data-driven...

10.48550/arxiv.2501.11868 preprint EN arXiv (Cornell University) 2025-01-20

Web-based cognitive behavioral therapy (wb-CBT) is a scalable way to reach distressed university students. Guided wb-CBT typically superior self-guided over short follow-up periods, but evidence less clear longer periods. This study aimed compare short-term (3 months) and longer-term (12 aggregate effects of guided versus treatment as usual (TAU) in randomized controlled trial Colombian Mexican students carry out an initially unplanned secondary analysis the role differential predicted...

10.2196/64251 article EN cc-by JMIR Mental Health 2025-02-28

There is a very high suicide rate in the year after psychiatric hospital discharge. Intensive postdischarge case management programs can address this problem but are not cost-effective for all patients. This issue be addressed by developing risk model to predict which inpatients might need such program. We developed 391,018 short-term admissions of US veterans Veterans Health Administration (VHA) hospitals 2010-2013. Records were linked with National Death Index determine within 12 months...

10.3389/fpsyt.2020.00390 article EN cc-by Frontiers in Psychiatry 2020-05-06

There is an extensive literature on the estimation and evaluation of optimal individualized treatment rules in settings where all confounders effect outcome are observed. We study development decision some these may not have been measured but a valid binary instrument available for treatment. first consider rules, which will naturally be most interesting it feasible to intervene directly then setting intervening infeasible, encourage feasible. In both settings, we also handle case that...

10.1080/01621459.2020.1745814 article EN Journal of the American Statistical Association 2020-03-20

<h3>Importance</h3> Little guidance exists to date on how select antipsychotic medications for patients with first-episode schizophrenia. <h3>Objective</h3> To develop a preliminary individualized treatment rule (ITR) <h3>Design, Setting, and Participants</h3> This prognostic study obtained data from Taiwan's National Health Insurance Research Database prescribed medications, ambulatory claims, or discharge diagnoses of schizophrenic disorder between January 1, 2005, December 31, 2011. An...

10.1001/jamanetworkopen.2019.21660 article EN cc-by-nc-nd JAMA Network Open 2020-02-21
Coming Soon ...